Breaking News: PFE – Market Insights, Analysis & Latest Updates

Analysis-RFK Jr vow to purge FDA sets up collision with Big Pharma

Robert F. Kennedy Jr. plans to reform the FDA, but faces industry pushback due to his controversial views on vaccines and potential staffing changes under Trump's administration.

investing.com • 15/11/2024 - 11:04 AM

Futures drop as Powell signals no hurry on rate cuts

U.S. stock futures decrease after Powell notes no urgent rate cuts needed. Bond yields rise, impacting equities. Vaccine stocks suffer amid new Health Secretary's appointment. Economic data ahead.

investing.com • 15/11/2024 - 10:58 AM

PFE
US500

Exclusive-Pfizer explores sale of hospital drugs unit, sources say

Pfizer is exploring the sale of its hospital drugs unit amid pressure from Starboard Value, aiming to reduce non-core assets and long-term debt while assessing buyer interest.

investing.com • 12/11/2024 - 14:47 PM

Novavax stock soars as FDA removes clinical hold on its COVID and influenza shot

The FDA has lifted its hold on Novavax's COVID-influenza vaccine trials, following clarifications that symptoms reported by a participant were linked to ALS, not the vaccine.

investing.com • 11/11/2024 - 13:57 PM

Moderna reports surprise profit on higher-than-expected COVID vaccine sales

Moderna reports a surprise Q3 profit driven by cost cuts and strong COVID vaccine sales but faces challenges with lower RSV vaccine revenue and competition.

investing.com • 07/11/2024 - 11:33 AM

Stocks to watch as White House race enters final stretch

The article discusses expectations around stock markets ahead of the U.S. presidential election, highlighting potential impacts from either Trump or Harris on various sectors and stocks.

investing.com • 01/11/2024 - 14:42 PM

Ford, PayPal and DR Horton fall premarket; Pfizer rises

US stock futures are steady as investors await corporate earnings, with significant premarket movers like Ford and Pfizer reacting to earnings results.

investing.com • 29/10/2024 - 12:09 PM

PFE

Pfizer raises profit forecast after beating third-quarter estimates

Pfizer raised its profit forecast after strong COVID treatment sales, exceeding earnings estimates amid pressure from an activist hedge fund to improve company performance.

investing.com • 29/10/2024 - 10:57 AM

PFE

Pfizer raises full-year guidance, beats Q3 estimates; shares climb

Pfizer's Q3 results exceeded estimates, prompting a 2% stock rise and an increase in their 2024 earnings and revenue guidance.

investing.com • 29/10/2024 - 10:55 AM

PFE

Pfizer earnings beat by $0.44, revenue topped estimates

Pfizer's Q3 EPS at $1.06 exceeds estimates; revenue at $17.7B. FY 2024 guidance suggests EPS of $2.75-$2.95 and revenue of $61.00B-$64.00B.

investing.com • 29/10/2024 - 10:48 AM

Currency